Alprolix Kit
Product Images NDC 71104-944

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Alprolix (NDC 71104-944). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bioverativ Therapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Alp0b 0002 01)

FDA Label Image

Figure (Alp0b 0002 02)

FDA Label Image

Figure (Alp0b 0002 03)

FDA Label Image

Figure (Alp0b 0002 04)

FDA Label Image

Figure (Alp0b 0002 05)

FDA Label Image

Figure (Alp0b 0002 06)

FDA Label Image

Figure (Alp0b 0002 07)

FDA Label Image

Figure (Alp0b 0002 08)

FDA Label Image

Figure (Alp0b 0002 09)

FDA Label Image

Figure (Alp0b 0002 10)

FDA Label Image

Figure (Alp0b 0002 11)

FDA Label Image

Figure (Alp0b 0002 12)

FDA Label Image

Figure (Alp0b 0002 13)

FDA Label Image

Figure (Alp0b 0002 14)

FDA Label Image

Figure (Alp0b 0002 15)

FDA Label Image

Figure (Alp0b 0002 16)

FDA Label Image

Figure (Alp0b 0002 17)

FDA Label Image

Figure (Alp0b 0002 18)

FDA Label Image

Figure (Alp0b 0002 19)

FDA Label Image

Figure (Alp0b 0002 20)

FDA Label Image

Figure (Alp0b 0002 21)

FDA Label Image

Figure (Alp0b 0002 22)

FDA Label Image

Figure (Alp0b 0002 23)

FDA Label Image

Figure (Alp0b 0002 24)

FDA Label Image

Figure (Alp0b 0002 25)

FDA Label Image

Figure (Alp0b 0002 26)

FDA Label Image

Principal Display Panel (250 IU Nominal Carton Label)

ALPROLIX is a medication used for intravenous administration containing Coagulation Factor X. It is a recombinant, Fc fusion protein manufactured by Bioverativ Therapeutics. The package comes with a single-use vial containing lyophilized powder. Once constituted with the provided diluent, it should be used within three hours and can be stored at room temperature for up to 3 hours or refrigerated. The recommended dosage and administration must be followed as stated on the label. NDC7110491101 is the National Drug Code for the product.*

FDA Label Image

Principal Display Panel (500 IU Nominal Carton Label)

FDA Label Image

Principal Display Panel (1000 IU Nominal Carton Label)

FDA Label Image

Principal Display Panel (2000 IU Nominal Carton Label)

ALPROLIX® is a coagulation factor X recombinant fusion protein that comes in a single-use vial containing 1 powder for reconstitution into a solution. The package also includes a prefilled diluent syringe containing 5 milliliters of 325% sodium chloride solution with a plunger, and a sterile vial adapter for reconstitution. The recommended storage temperature is under refrigeration at 2°C to 8°C (36°F to 46°F), with the product lasting up to a month at room temperature of 30°C (86°F) or less. Users should not return room temperature products to refrigeration. The package warns users not to use past the expiration date listed on the label and to protect the product from light. When reconstituted, ALPROLIX® can be used within three hours at room temperature or 24 hours under refrigeration. The product can be stored at room temperature (around 30°C/86°F) for immediate use within three hours. A 30001U nominal dosage comes with the package and users should refer to the enclosed package insert for dosage and administration instructions. Contains no preservative and ingredients include mannitol, sodium chloride, sodium citrate, and polysorbate 20. The manufacturer is Bioverativ Therapeutics located in Waltham, Massachusetts.*

FDA Label Image

Principal Display Panel (3000 IU Nominal Carton Label)

FDA Label Image

Principal Display Panel (4000 IU Nominal Carton Label)

This is a product description and dosage instructions for ALPROLIX, a coagulation factor IX recombinant fusion protein for intravenous administration. The package contains a single-use vial containing a lyophilized powder and a pre-filled syringe containing the reconstitution solution. The product should be stored in refrigeration and administered at room temperature. The text also includes manufacturing information and ingredients contained in the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.